Effect of intraperitoneally administered recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) on the cytotoxic potential of murine peritoneal cells
1999

Effect of a Protein on Immune Cells in Mice

publication

Author Information

Author(s): Klimp A H, Regts J, Scherphof G L, de Vries E G E, Daemen T

Primary Institution: Groningen Institute for Drug Studies

Hypothesis

The study investigates how recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) affects the cytotoxic potential of murine peritoneal cells.

Conclusion

The expanded peritoneal cell population induced by rmGM-CSF has a strong tumor cytotoxic potential, which may enhance immunotherapy for peritoneal neoplasms.

Supporting Evidence

  • Daily injection of rmGM-CSF increased peritoneal cell numbers over tenfold.
  • The highest dose of rmGM-CSF led to a significant increase in macrophage numbers.
  • Peritoneal cells from treated mice could achieve high levels of cytotoxicity with additional stimulation.

Takeaway

Researchers gave mice a special protein to see if it would help their immune cells fight tumors better, and it turned out that it did help a lot.

Methodology

Mice received different dosages of rmGM-CSF intraperitoneally, and their peritoneal cells were isolated to assess tumor cytotoxicity through a cytotoxicity assay.

Participant Demographics

Mice were used in the study.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690016

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication